These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25456349)
1. Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy. Tchekalarova JD; Ivanova NM; Pechlivanova DM; Atanasova D; Lazarov N; Kortenska L; Mitreva R; Lozanov V; Stoynev A Pharmacol Biochem Behav; 2014 Dec; 127():27-36. PubMed ID: 25456349 [TBL] [Abstract][Full Text] [Related]
2. Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral alterations in spontaneously hypertensive rats in kainate model of temporal lobe epilepsy. Petkova Z; Tchekalarova J; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Popov D; Markova P; Lozanov V; Atanasova D; Lazarov N; Stoynev A Epilepsy Behav; 2014 Feb; 31():198-208. PubMed ID: 24440891 [TBL] [Abstract][Full Text] [Related]
3. Losartan suppresses the kainate-induced changes of angiotensin AT Atanasova D; Tchekalarova J; Ivanova N; Nenchovska Z; Pavlova E; Atanassova N; Lazarov N Life Sci; 2018 Jan; 193():40-46. PubMed ID: 29223539 [TBL] [Abstract][Full Text] [Related]
4. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy. Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504 [TBL] [Abstract][Full Text] [Related]
5. Long-term intracerebroventricular infusion of angiotensin II after kainate-induced status epilepticus: Effects on epileptogenesis, brain damage, and diurnal behavioral changes. Ivanova NM; Atanasova D; Pechlivanova DM; Mitreva R; Lazarov N; Stoynev AG; Tchekalarova JD Epilepsy Behav; 2015 Oct; 51():1-12. PubMed ID: 26245156 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy. Tchekalarova JD; Ivanova N; Atanasova D; Pechlivanova DM; Lazarov N; Kortenska L; Mitreva R; Lozanov V; Stoynev A Cell Mol Neurobiol; 2016 Aug; 36(6):927-941. PubMed ID: 26464042 [TBL] [Abstract][Full Text] [Related]
7. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats. Rattka M; Brandt C; Löscher W Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy. Tchekalarova J; Petkova Z; Pechlivanova D; Moyanova S; Kortenska L; Mitreva R; Lozanov V; Atanasova D; Lazarov N; Stoynev A Epilepsy Behav; 2013 Apr; 27(1):174-87. PubMed ID: 23435277 [TBL] [Abstract][Full Text] [Related]
9. Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy. Kiasalari Z; Roghani M; Khalili M; Rahmati B; Baluchnejadmojarad T Pharm Biol; 2013 Dec; 51(12):1572-8. PubMed ID: 24004105 [TBL] [Abstract][Full Text] [Related]
10. Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar-Kyoto and spontaneously hypertensive rats. Tchekalarova J; Loyens E; Smolders I Epilepsy Behav; 2015 May; 46():66-71. PubMed ID: 25922088 [TBL] [Abstract][Full Text] [Related]
11. Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy. Tchekalarova J; Pechlivanova D; Atanasova T; Markova P; Lozanov V; Stoynev A Epilepsy Behav; 2011 Feb; 20(2):277-85. PubMed ID: 21277833 [TBL] [Abstract][Full Text] [Related]
12. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid. Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690 [TBL] [Abstract][Full Text] [Related]
13. Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats. Linard B; Ferrandon A; Koning E; Nehlig A; Raffo E Epilepsia; 2010 Sep; 51(9):1829-36. PubMed ID: 20633040 [TBL] [Abstract][Full Text] [Related]
14. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Twele F; Bankstahl M; Klein S; Römermann K; Löscher W Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899 [TBL] [Abstract][Full Text] [Related]
15. Effect of endurance training on seizure susceptibility, behavioral changes and neuronal damage after kainate-induced status epilepticus in spontaneously hypertensive rats. Tchekalarova J; Shishmanova M; Atanasova D; Stefanova M; Alova L; Lazarov N; Georgieva K Brain Res; 2015 Nov; 1625():39-53. PubMed ID: 26319691 [TBL] [Abstract][Full Text] [Related]
16. Rosmarinic acid exerts a neuroprotective effect in the kainate rat model of temporal lobe epilepsy: Underlying mechanisms. Khamse S; Sadr SS; Roghani M; Hasanzadeh G; Mohammadian M Pharm Biol; 2015; 53(12):1818-25. PubMed ID: 25874386 [TBL] [Abstract][Full Text] [Related]
17. Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms. Sedaghat R; Taab Y; Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Roghani M Biomed Pharmacother; 2017 Mar; 87():200-208. PubMed ID: 28061403 [TBL] [Abstract][Full Text] [Related]
18. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. François J; Koning E; Ferrandon A; Nehlig A Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504 [TBL] [Abstract][Full Text] [Related]
19. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Polascheck N; Bankstahl M; Löscher W Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis. Ramazi S; Fahanik-Babaei J; Mohamadi-Zarch SM; Tashakori-Miyanroudi M; Nourabadi D; Nazari-Serenjeh M; Roghani M; Baluchnejadmojarad T J Chem Neuroanat; 2020 Oct; 108():101800. PubMed ID: 32430101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]